RIPK2 and cancer: Moreover, these mechanistic findings are clinically relevant because (1) RIPK2 and MYC are frequently co-amplified/gained in lethal PC and several other cancer types, and (2) RIPK2 and MYC activity scores are strongly correlated in clinical tissue specimens of 32 cancer types.